Allergan rose$. 84 or. 5 percent, to $184.21. Baxter International Inc. rose$. 73 or 1.1 percent, to $69.83. Boston Scientific Corp. rose$. 28 or 2.2 percent, to $12.99.» Read More
Allergan fell $4.40 or 2.4 percent, to $177.59. Baxter International Inc. fell$. 52 or. 8 percent, to $68.34. Boston Scientific Corp. fell$. 12 or 1.0 percent, to $11.44.
Allergan fell $8.30 or 4.6 percent, to $173.69. Baxter International Inc. fell $1.69 or 2.5 percent, to $67.17. Boston Scientific Corp. fell$. 32 or 2.7 percent, to $11.25.
Allergan fell $5.93 or 3.3 percent, to $176.06. Baxter International Inc. fell $1.10 or 1.6 percent, to $67.76. Boston Scientific Corp. fell$. 13 or 1.1 percent, to $11.43.
Oct 15- Heart device maker St. Jude Medical Inc forecast a quarterly revenue that fell below Wall Street estimate, and said sales growth in international markets didn't match its expectation. The maker of pacemakers, implantable defibrillators, artificial heart valves, stents and neurological products said it expects an adjusted profit of $1.02- $1.04 per...
LONDON, Oct 15- ConvaTec's owners have appointed Morgan Stanley and Goldman Sachs to explore a sale of the medical device maker which could be worth up to $10 billion, sources familiar with the matter said. Private equity firms Avista Capital Partners and Nordic Capital are preparing the groundwork for a possible sale or initial public offering in 2015 for the...
Allergan rose $3.71 or 2.1 percent, to $181.99. Baxter International Inc. fell$. 80 or 1.1 percent, to $68.86. Boston Scientific Corp. fell$. 18 or 1.5 percent, to $11.56.
Allergan rose $2.64 or 1.5 percent, to $180.92. Baxter International Inc. rose$. 01 or percent, to $69.67. Boston Scientific Corp. rose$. 02 or. 2 percent, to $11.76.
Allergan fell $2.92 or 1.6 percent, to $175.36. Baxter International Inc. rose$. 02 or percent, to $69.68. Boston Scientific Corp. fell$. 06 or. 5 percent, to $11.68.
Allergan fell $2.27 or 1.2 percent, to $185.35. Baxter International Inc. fell$. 52 or. 7 percent, to $70.73. Boston Scientific Corp. rose$. 08 or. 6 percent, to $12.00.
Allergan fell $1.25 or. 7 percent, to $186.36. Baxter International Inc. fell$. 38 or. 5 percent, to $70.87. Boston Scientific Corp. rose$. 05 or. 4 percent, to $11.97.
The first trial of an Ebola vaccine has started with the vaccination of three health care workers in Mali, researchers told NBC News.
DALLAS, Oct 7- The Ebola patient fighting for his life in a Dallas hospital is on a ventilator and a kidney dialysis machine to help stabilize his health, the hospital said on Tuesday. Authorities in the United States and the public are on alert following Duncan's diagnosis more than a week ago, which raised concerns that the worst epidemic of Ebola on record could...
The announcement is the latest in a recent spate of multibillion-dollar healthcare sector deals.
Another day, another new wrist-wearable in gadgetland. But this one sounds … pretty compelling. Re/code explains.
NEW YORK, Sept 26- U.S. medical device maker Medtronic Inc is likely to try to renegotiate the structure and terms of its $42.9 billion deal to buy Ireland's Covidien Plc in response to new U.S. tax rules, according to people familiar with the situation.
SHANGHAI, Sept 4- A Chinese anti-monopoly team visited medical devices and semi-conductor firms in Shanghai at the start of September, the country's Ministry of Commerce said in a statement on Thursday, without making clear the purpose of the visit.
Sept 2- General Electric Co's healthcare unit last week won U.S. Food and Drug Administration approval for its mammography device that produces three-dimensional images to detect breast cancer. Hologic Inc came up with one of the first 3- D breast imaging devices in 2001, which continues to dominate the market.
BARCELONA, Sept 1- A nerve stimulation device from Cyberonics improved cardiac function in heart failure patients in a small clinical trial, in contrast to an unsuccessful study backed by Boston Scientific.
BARCELONA, Aug 31- Swiss engineers, famous for making the world's finest watches, are turning their hands to cardiology with a prototype battery-less pacemaker based on a self-winding wristwatch.
Aug 28- Johnson& Johnson plans to seek a buyer for its medical device maker business, Cordis Corp, The Wall Street Journal reported citing people familiar with the matter. Earlier this year, J&J sold another of its units, Ortho-Clinical Diagnostics Inc to private-equity firm Carlyle Group for $4.15 billion.